{"id":"W2947422641","doi":"10.1016/s1665-2681(19)30843-9","title":"A phase 2 study of filibuvir in combination with pegylated IFN alfa and ribavirin for chronic HCV","year":2014,"lang":"en","type":"article","venue":"Annals of Hepatology","topic":"Hepatitis C virus research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"Pfizer","keywords":"Ribavirin; Medicine; Internal medicine; Gastroenterology; Nausea; Adverse effect; Placebo; Pegylated interferon; Clinical endpoint; Hepatitis C virus; Hepatitis C; Randomized controlled trial; Immunology; Virus","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004932731,0.00009702697,0.0004999631,0.0002700992,0.00002121315,0.00000250953,0.00007041721,0.00008589267,0.00003021516],"category_scores_gemma":[0.0003762734,0.00008182949,0.00002643872,0.00020575,0.0001441459,0.00005402533,0.00003373786,0.0001240708,0.000002093844],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001683491,"about_ca_system_score_gemma":0.0001177485,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007739402,"about_ca_topic_score_gemma":0.002124012,"domain_scores_codex":[0.9988369,0.0001798133,0.0003500535,0.0002127549,0.0001777694,0.0002426815],"domain_scores_gemma":[0.999041,0.0002397556,0.000115795,0.0002259323,0.0003082378,0.00006923808],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00503811,0.009094492,0.8131973,0.0007178711,0.0002503396,0.00006895548,0.001606087,0.000007898074,0.004623405,0.0009388025,0.001170717,0.163286],"study_design_scores_gemma":[0.1547667,0.2995051,0.3719833,0.000604719,0.0002483084,0.0000856876,0.0008298947,0.08483782,0.06096096,0.002338971,0.02318244,0.0006560581],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9970611,0.0002047221,0.000106714,0.001224126,0.00001478652,0.001037481,0.00001089045,0.0000104411,0.0003296811],"genre_scores_gemma":[0.9995406,0.0001077453,0.00007953771,0.00009653666,0.00001058802,0.00008089717,0.00002793719,0.00001524419,0.00004090783],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.441214,"threshold_uncertainty_score":0.333691,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08095083295401598,"score_gpt":0.4213288046548228,"score_spread":0.3403779717008069,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}